Asymmetric catalysis in synthetic strategies for chiral benzothiazepines

被引:47
作者
Wang, Haifeng [1 ,2 ]
Gu, Shuangxi [1 ,2 ]
Yan, Qiongjiao [1 ,2 ]
Ding, Li [3 ]
Chen, Fen-Er [1 ,2 ,3 ,4 ]
机构
[1] Wuhan Inst Technol, Sch Chem Engn & Pharm, Wuhan 430205, Peoples R China
[2] Wuhan Inst Technol, Pharmaceut Res Inst, Wuhan 430205, Peoples R China
[3] Fudan Univ, Engn Ctr Catalysis & Synth Chiral Mol, Dept Chem, Shanghai 200433, Peoples R China
[4] Shanghai Engn Ctr Ind Catalysis Chiral Drugs, Shanghai 200433, Peoples R China
来源
GREEN SYNTHESIS AND CATALYSIS | 2020年 / 1卷 / 01期
基金
中国国家自然科学基金;
关键词
Chiral benzothiazepine; Asymmetric catalysis; Metal catalysis; Enzymatic catalysis; Organic catalysis; 1,5-BENZOTHIAZEPINE DERIVATIVE CRD-401; 3-PHENYLGLYCIDIC ACID-ESTER; SULFA-MICHAEL ADDITION; KEY INTERMEDIATE; ENANTIOSELECTIVE SYNTHESIS; EFFICIENT SYNTHESIS; DILTIAZEM ANALOGS; NET CYCLOADDITION; EPOXIDATION; DIHYDROXYLATION;
D O I
10.1016/j.gresc.2020.05.005
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Chiral benzothiazepines constitute the core structures of many foremost pharmaceuticals with diverse biological activities endowed by their unique scaffolds, which poses a great challenge to organic chemists and pharmaceutical researchers. This review provides a concise overview for the asymmetric synthesis of chiral benzothiazepine derivatives, focusing on advances in asymmetric catalysis, including metal catalysis, small-molecule organocatalysis and enzymatic catalysis. The catalytic asymmetric reactions, involving asymmetric epoxidation, reduction, dihydroxylation, hydrogenation, aldol reaction and other sulfa-Michael addition, have emerged as powerful strategies for the rapid construction of chiral benzothiazepine through single or multistep reactions. The booming asymmetric synthetic methodology affords us instructive clues for the highly efficient preparation of chiral benzothiazepines, facilitating their large-scale preparation and diversity-oriented synthesis.
引用
收藏
页码:12 / 25
页数:14
相关论文
共 65 条
[1]  
AKITA H, 1991, CHEM PHARM BULL, V39, P1632
[2]  
AKITA H, 1989, CHEM PHARM BULL, V37, P2876
[3]  
[Anonymous], 2012, Angew. Chem
[4]   Catalytic Approaches to Optically Active 1,5-Benzothiazepines [J].
Asano, Keisuke ;
Matsubara, Seijiro .
ACS CATALYSIS, 2018, 8 (07) :6273-6282
[5]  
ASANO T, 1986, CHEM PHARM BULL, V34, P4238
[6]   1,5-Benzothiazepine, a versatile pharmacophore: A review [J].
Bariwal, Jitender B. ;
Upadhyay, Kuldip D. ;
Manvar, Atul T. ;
Trivedi, Jalpa C. ;
Singh, Jyoti S. ;
Jain, Kishor S. ;
Shah, Anarmik K. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2008, 43 (11) :2279-2290
[7]  
Brieaddy L. E., 1996, [No title captured], Patent No. [WO9616051, 9616051]
[8]   Ligands of Diltiazem Binding Site: An Overview of Some Chemotypes [J].
Budriesi, R. ;
Ioan, P. ;
Carosati, E. ;
Cruciani, G. ;
Zhorov, B. S. ;
Chiarini, A. .
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2009, 9 (12) :1379-1388
[9]   Diltiazem analogues: The last ten years on structure activity relationships [J].
Budriesi, Roberta ;
Cosimelli, Barbara ;
Ioan, Pierfranco ;
Carosati, Emanuele ;
Ugenti, Maria P. ;
Spisani, Rraffaella .
CURRENT MEDICINAL CHEMISTRY, 2007, 14 (03) :279-287
[10]   A trifunctional catalyst for one-pot synthesis of chiral Diols via Heck coupling-N-oxidation-asymmetric dihydroxylation: Application for the synthesis of diltiazem and Taxol side chain [J].
Choudary, BM ;
Chowdari, NS ;
Madhi, S ;
Kantam, ML .
JOURNAL OF ORGANIC CHEMISTRY, 2003, 68 (05) :1736-1746